These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19999281)

  • 1. [Tic-related obsessive-compulsive disorder].
    Kanao Y
    Seishin Shinkeigaku Zasshi; 2009; 111(7):810-5. PubMed ID: 19999281
    [No Abstract]   [Full Text] [Related]  

  • 2. Obsessive-compulsive disorders.
    Thomsen PH
    Eur Child Adolesc Psychiatry; 2013 Feb; 22 Suppl 1():S23-8. PubMed ID: 23208425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of the resistant obsessive-compulsive disorder: an update].
    Crespo Facorro B; Gomez-Hernández R
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(1):61-9. PubMed ID: 9133159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome.
    Bloch MH; Peterson BS; Scahill L; Otka J; Katsovich L; Zhang H; Leckman JF
    Arch Pediatr Adolesc Med; 2006 Jan; 160(1):65-9. PubMed ID: 16389213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole treatment in an adolescent patient with chronic motor tic disorder and treatment-resistant obsessive-compulsive disorder.
    Lai CH
    Int J Neuropsychopharmacol; 2009 Oct; 12(9):1291-3. PubMed ID: 19706223
    [No Abstract]   [Full Text] [Related]  

  • 6. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
    Bloch MH; Landeros-Weisenberger A; Kelmendi B; Coric V; Bracken MB; Leckman JF
    Mol Psychiatry; 2006 Jul; 11(7):622-32. PubMed ID: 16585942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transient tic disorder].
    Kano Y
    Ryoikibetsu Shokogun Shirizu; 2003; (40):59-64. PubMed ID: 14626065
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.
    McDougle CJ; Goodman WK; Price LH; Delgado PL; Krystal JH; Charney DS; Heninger GR
    Am J Psychiatry; 1990 May; 147(5):652-4. PubMed ID: 1970224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Again and again--the obsessive circle can be broken].
    Rück C; Andersson EM; Andréewitch S; Bejerot S; Ivarsson T; Bates S; Lindefors N
    Lakartidningen; 2011 Apr 6-12; 108(14):798-801. PubMed ID: 21638920
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
    Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obsessive-compulsive disorder and tic syndromes.
    Swerdlow NR
    Med Clin North Am; 2001 May; 85(3):735-55. PubMed ID: 11349482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of a patient with both psychotic and obsessive-compulsive symptoms.
    Rodriguez CI; Corcoran C; Simpson HB
    Am J Psychiatry; 2010 Jul; 167(7):754-61. PubMed ID: 20595428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Error-related negativity and tic history in pediatric obsessive-compulsive disorder.
    Hanna GL; Carrasco M; Harbin SM; Nienhuis JK; LaRosa CE; Chen P; Fitzgerald KD; Gehring WJ
    J Am Acad Child Adolesc Psychiatry; 2012 Sep; 51(9):902-10. PubMed ID: 22917203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of pharmacotherapy for obsessive-compulsive disorder may lie in a better understanding of its heterogeneity.
    Brakoulias V
    Expert Opin Pharmacother; 2014 Jul; 15(10):1321-3. PubMed ID: 24866422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.
    March JS; Franklin ME; Leonard H; Garcia A; Moore P; Freeman J; Foa E
    Biol Psychiatry; 2007 Feb; 61(3):344-7. PubMed ID: 17241830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent class analysis of the Yale-Brown Obsessive-Compulsive Scale symptoms in obsessive-compulsive disorder.
    Delucchi KL; Katerberg H; Stewart SE; Denys DA; Lochner C; Stack DE; den Boer JA; van Balkom AJ; Jenike MA; Stein DJ; Cath DC; Mathews CA
    Compr Psychiatry; 2011; 52(3):334-41. PubMed ID: 21145539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobiology of obsessive compulsive disorder.
    Wright M; Hewlett WA
    Compr Ther; 1994; 20(2):95-100. PubMed ID: 7911407
    [No Abstract]   [Full Text] [Related]  

  • 18. [Obsessive-compulsive disorder and schizophrenia].
    Denda K
    Ryoikibetsu Shokogun Shirizu; 2003; (38):459-63. PubMed ID: 12877026
    [No Abstract]   [Full Text] [Related]  

  • 19. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial.
    Bogetto F; Bellino S; Vaschetto P; Ziero S
    Psychiatry Res; 2000 Oct; 96(2):91-8. PubMed ID: 11063782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tic disorders].
    Janik P
    Neurol Neurochir Pol; 2002; 36(6):1251-3. PubMed ID: 12715703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.